Gynecologic Cancer
From the Journals
Cancer rates on the rise in adolescents and young adults
Conference Coverage
Cervical cancer recurrence patterns differ after laparoscopic and open hysterectomy
The likelihood of recurrence at certain sites and the timing of recurrence may relate to the surgical approach.
Conference Coverage
Immune checkpoint inhibitors don’t increase COVID-19 incidence or mortality, studies suggest
Cancer patients treated with immune checkpoint inhibitors are not significantly more likely to develop or die from COVID-19, two studies suggest...
From the Journals
New findings on ‘exceptional responders’ to cancer therapies
Why do a small percentage of cancer patients show exceptional responses to therapy? The answer may lie in their genetic makeup.
From the Journals
Half of women treated for gynecologic cancers miss or skip doses of oral drugs
Those who did not take all their medications cited anxiety or expressed doubt about the efficacy of their regimens.
From the Journals
Two-drug combo should be first-line standard of care in advanced endometrial cancer
Survival outcomes for the combination paclitaxel-carboplatin were similar to those with paclitaxel, doxorubicin, and cisplatin but with lower...
Clinical Insights
Using telehealth to deliver palliative care to cancer patients
Dr. Alan Lyss discusses the use of telehealth for palliative cancer care, including results from the REACH PC trial.
Conference Coverage
Low threshold to biopsy atypical lesions may ID vulvar melanoma early, experts say
To diagnose one melanoma, doctors may need to biopsy many lesions.
From the Journals
New cancer drugs may have saved more than 1.2 million Americans
Cancer drugs approved between 2000 and 2016 significantly reduced deaths from the most common cancers in the United States.
From the Journals
‘Test all patients with cancer’: One in eight have inherited mutations
Nearly half of mutations identified in this study would have been missed under current guidelines.
From the Journals
Rare event: Iatrogenic injury during cervical cancer screening